CRO George Clinical extends oncology research in Asia Pacific and US
Asia Pacific-based CRO George Clinical has acquired Vector Oncology's CRO division in the US to expand cancer research across the regions.
Archives for May 2, 2017
EC warns UK pharma to review drug authorisations ahead of Brexit
The European Commission has urged UK Pharma firms to check how Brexit will impact their drugs, pointing out that EU law requires that authorisation holders have a base in a member state or EEA country.
US FDA warns Indian API maker for faking certificates of analysis
Falsified certificates of analysis (COA) and misbranding violations have landed Indian API maker Sal Pharma a US FDA warning letter.
endpoint extends IRT accessibility across clinical development portfolio
endpoint has combined features of its IRT platform with its global inventory management tool, DRIVE, to extend IRT accessibility across the clinical development portfolio.
INC Research receives workforce quality accreditation
INC Research Holdings, Inc. has received the “Silver Standard” as part of IAOCR's Clinical Operations Workforce Quality Accreditation program.
PE backer stumps up $12.3m to help Teewinot grow cannabinoid business
Teewinot Life Sciences has closed a $12.3m (€11.2m) deal with investment manager Tuatara Capital.
WIRB, Huron align as clinical research industry challenges mount
WIRB-Copernicus Group (WIRB) and Huron have announced an alliance to support research programs in the face of heightened expectations from industry sponsors.
Astrazeneca and Pieris team to develop mAb-like drugs for lung diseases
Astrazeneca has teamed up with Pieris Pharmaceuticals Inc to develop antibody like mini proteins for the treatment of lung diseases.